| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/08/2008 | US20080108596 Antiserotonine agents; psycholgical disorders; headaches; kits |
| 05/08/2008 | US20080108595 Inhibitors of cathepsin s |
| 05/08/2008 | US20080108594 Antithrombotic Ethers |
| 05/08/2008 | US20080108593 metal phthalocyanine ; antiallergen; enzyme-like catalyst reaction of metal phthalocyanine; allergen is denatured by ability of adsorbing of the metal phthalocyanine and reacting as a catalyst on an oxidation-reduction reaction |
| 05/08/2008 | US20080108592 treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/08/2008 | US20080108590 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/08/2008 | US20080108589 Method of treatment with coadministration of aspirin and prasugrel |
| 05/08/2008 | US20080108588 NO-alendronate; NO-pamidronate; NO-clodronate; NO-risedronate; NO-zolendronate; NO-etidronate; NO-ibandronate; NO-tiludronate; NO-neridronate; NO-olpadronate; NO-icadronate; NO-YH529; additional agent such as growth hormones, bone morphogenic proteins enhances bone growth or decreases bone resorption |
| 05/08/2008 | US20080108587 Cartilage regeneration promoting agent |
| 05/08/2008 | US20080108586 Combination therapy for human immunodeficiency virus infection |
| 05/08/2008 | US20080108584 dsRNA with a sense strand containing a first sequence, an antisense strand containing a second sequence, comprises a nucleotide sequence which is substantially complementary to mRNA encoding IKK-B, upon contact with a cell expressing IKK-B, Inhibits IKK-B gene expression; antiinflammatory agent |
| 05/08/2008 | US20080108583 Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes |
| 05/08/2008 | US20080108582 Methods And Compositions For Combinatorial Approaches To Cancer Gene Therapy |
| 05/08/2008 | US20080108581 consist of DNA sequence-specific ligand capable of recognizing sequence common to genes of pathological interest ( as IGF-1, IGF-1R, VEGF, BCL2), linker arm, and topoisomerase I posion (as camptothecins, rebeccamycins, minor groove ligands, benzimidazoles); dismetabolic, autoimmune diseases, HIV and HCV |
| 05/08/2008 | US20080108580 1-Bromo-4-deoxy-4-fluoro-2,3,6-tri-O-acetyl-alpha-D-galactose derivatives; antidiabetic agent |
| 05/08/2008 | US20080108579 macrolide or macrolide analog such tacrolimus, sirolimus, everolimus, pimecrolimus as is administered to a post-ocular surgery patient to reduce or minimize ocular scarring |
| 05/08/2008 | US20080108576 Novel cytostatic conjugates with integrin ligands |
| 05/08/2008 | US20080108575 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 05/08/2008 | US20080108574 Melanocortin receptor mediated modulation of neurogenesis |
| 05/08/2008 | US20080108568 administering a sulfonamide compound containing quinoline and 1,4-diazapine rings, with a nitric oxide enhancer selected from the group consisting of a PDE5 inhibitor, a nitric oxide donor molecules, or a HMG Co A Reductase |
| 05/08/2008 | US20080108561 DNA molecule corresponding to a nucleotide sequence of a cereal pollen major allergen; therapy of pollen-allergy diseases |
| 05/08/2008 | US20080108559 Compositions and methods for treating diseases through inhibition of dna methylation and histone deacetylase |
| 05/08/2008 | US20080108558 Cross-linked glycopeptide-cephalosporin antibiotics |
| 05/08/2008 | US20080108555 Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute |
| 05/08/2008 | US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer |
| 05/08/2008 | US20080108139 Composition of matter comprising primary nucleic acid component |
| 05/08/2008 | US20080107761 Extracts of Caesalpinia crista, extracts of Psophocarpus tetragonolobus, phytic acid, and L- hydroxyproline and a pharmaceutically acceptable salt |
| 05/08/2008 | US20080107759 Bamboo of Sasa genus or Phyllostachys genus; extracted with water, alcohol, non-polar hexane, ethyl acetate, chloroform and dichloromethane |
| 05/08/2008 | US20080107758 Mixture with alcohol, propellant and isopropyl myristate; antiinflammatory agents; clobetasol proprionate, fluocinonide, triamcinolone acetonide, fluocinolene acetonide; black cumin, black raspberry, red raspberry, pumpkin seed oil, chardonnay grape seed oil, carrot seed oil; skin disorders |
| 05/08/2008 | US20080107756 Lithium combinations, and uses related thereto |
| 05/08/2008 | US20080107751 Wax bath is solid at room temperature; an anti-microbial agent inhibit growth of micro-organisms in the wax in the liquid state; fragrance; mineral oil, animal, vegetable oils; jojoba oil, emu oil, aloe vera oil; paraffin wax; hand, foot, elbow or other appendage is dipped or immersed in molten wax |
| 05/08/2008 | US20080107746 Anti-inflamatory inhalation pharmaceutical composition |
| 05/08/2008 | US20080107745 Controlled release sterile injectable aripiprazole formulation and method |
| 05/08/2008 | US20080107743 Enhancing ceramide synthesis; topical calcium glycerophosphate and a fatty acid source derived from an animal or a vegetable; inhibits dephosphorylation of spingosine-1-phosphate; enhances conversion of phosphatidyl choline to phosphocholine and of phosphocholine to sphingomyelin and to ceramide |
| 05/08/2008 | US20080107742 Alkalinizing agent, humectant, detergent, wetting agent, antibacterial agent, stabilizer, emulsifier, antifungal agent, colorants, moisturizer, thickening agent, preservative, filler, keratolytic agent; menthol, camphor counterirritants; granules, beads, microspheres, grit, pumice, polymer, sand, glass |
| 05/08/2008 | US20080107741 Angiogenesis inhibitor particles having a particle size of less than 2000 nm; and associated with the surface thereof at least one surface stabilizer |
| 05/08/2008 | US20080107740 Dry powder inhaler; metered dose nebulization; asthma or other inflammatory respiratory disorders; correct molecular ratio of salmeterol active in the lung while budesonide active in the lung can be ensured |
| 05/08/2008 | US20080107738 Ophthalmic Emulsions Containing Prostaglandins |
| 05/08/2008 | US20080107737 Crosslinked Amine Polymers |
| 05/08/2008 | US20080107736 Nanoparticulate suspension of a corticosteroid compound; a second solvent promotes active compound precipitation; substantially free of surfactant; optically clear; particulate of a desired particle size; prepared without the use of mechanical shearing; increased bioavailability |
| 05/08/2008 | US20080107734 Healing powder and method of use thereof |
| 05/08/2008 | US20080107730 Sustained release pharmaceutical preparations and methods for producing the same |
| 05/08/2008 | US20080107727 Multiple Unit Oral Sustained Release Preparation and Production Method Thereof |
| 05/08/2008 | US20080107726 Compositions comprising beta-adrenergic receptor antagonists and diuretics |
| 05/08/2008 | US20080107725 Physically unstable crystalline form of a therapeutically effective compound; rapid, reproducible, and complete dissolution profiles |
| 05/08/2008 | US20080107724 Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| 05/08/2008 | US20080107723 Methods of Treating Pulmonary Distress |
| 05/08/2008 | US20080107721 Combination Chemotherapy Comprising A Liposomal Platinum Complex |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107719 Transdermal drug delivery system |
| 05/08/2008 | US20080107714 Use of a vector comprising a nucleic acid encoding an anti-angiogenic factor for the treatment of corneal neovascularization |
| 05/08/2008 | US20080107712 Ocular implant made by a double extrusion process |
| 05/08/2008 | US20080107709 Radio-opaque polymeric biomaterials |
| 05/08/2008 | US20080107707 Polymerizable antimicrobial composition |
| 05/08/2008 | US20080107706 Osteogenic Oligonucleotides and Uses Thereof |
| 05/08/2008 | US20080107694 Glycolic acid-lactic acid copolymer; biocompatible; biodegradable; RNA interference; inhibitors of vascular endothelial growth factor (VEGF); ocular disorders |
| 05/08/2008 | US20080107693 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences |
| 05/08/2008 | US20080107662 Immunogenic Peptides, Nucleic Acids Encoding The Same And Use Thereof In Cancer Treatment And Diagnosis |
| 05/08/2008 | US20080107661 Using cell free system for identifying agents which prevent mucin and chronic myelogenous leukemia ligand binding; antitumor agents; treating cell proliferative, nervous system, inflammatory and atherosclerotic disorders |
| 05/08/2008 | US20080107656 Plasmodium specific immunoglobulin for use in prevention and treatment of parasitic infection; parasiticides |
| 05/08/2008 | US20080107652 Using transgenic, probiotic microorgansims as therapeutic vechicles for prevention and treatment of infection in shrimp |
| 05/08/2008 | US20080107650 Administering (S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]-ethylamino]-4-methylpentanoic acid for treatment of inflammatory bowel disease, Crohn's disease; corticosteroid free therapy |
| 05/08/2008 | US20080107647 Methods and Compositions Relating to Ccr5 Antagonist, Inf-Y and Il-13 Induced Inflammation |
| 05/08/2008 | US20080107646 Administering phenylbutyric acid derivative and pharmaceutically acceptable carrier |
| 05/08/2008 | US20080107643 Transmembrane polypeptide for use in identifying modulators for prevention and treatment of cell proliferative, fibrotic and sclerotic disorders |
| 05/08/2008 | US20080107639 Secreted glycoprotein for use in prevention and treatment of obesity, diabetes, osteoarthritis, liver and hypertensive disorders |
| 05/08/2008 | US20080107638 Mixture comprising long-chain primary aliphatic alcohol, B12 Vitamin, D Vitamin, coenzyme Q, and omega-3 fatty for use in prevention and treatment of tissue destructive inflammation |
| 05/08/2008 | US20080107637 Using inhalabe gas comprising ethyl nitrite as means of nitrosylating hemoglobin, delaying tumor growth and preventing destruuctive tissue damage associated with inflammation |
| 05/08/2008 | US20080107634 Using mix comprising bifidobacterium and lactobacillus as tool in treatment of gastrointestinal and influenzal disorders |
| 05/08/2008 | US20080107628 Phosphonate inhibitors of HCV |
| 05/08/2008 | US20080107626 Adjuvant agent for hepatitis C |
| 05/08/2008 | US20080107622 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies |
| 05/08/2008 | US20080107621 Use Of Il - 6 In Microvascular Complicaitions |
| 05/08/2008 | US20080107618 Use of fullerenes for the treatment of mast cell and basophil-mediated disease |
| 05/08/2008 | US20080107613 Pharmaceutical composition comprising a macrolide t-cell immunomodulator and anti-photoaging agent |
| 05/08/2008 | US20080107610 Breath freshening and oral cleansing product with magnolia bark extract |
| 05/08/2008 | US20080107609 Administering mometasone furoate and lactose particles from a multidose dry powder inhaler in daily doses of 800 mu g where at least about 250 mu g of the particles have sizes equal to or less than about 6.5 mu m. |
| 05/08/2008 | US20080107608 selective modulators of corticotropin -releasing factor (CRF) receptors, central and periphereal nervous system disorders; antidepressant, anxiolytic agent; stress, cardiovascular disorders, and eating disorders; probes for the localization of CRF receptors |
| 05/08/2008 | US20080107603 Administering L-ergothioneine; Alzheimer's disease, multiple sclerosis, stroke, traumatic brain injury, spinal cord injuries |
| 05/08/2008 | US20080107599 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 05/08/2008 | DE202008003004U1 Lutschpastille Lozenge |
| 05/08/2008 | DE202008002797U1 Medikamentengestützter Nikotinentzug Medication-assisted smoking cessation |
| 05/08/2008 | DE202008002263U1 Gesundheitsförderndes Mittel und dessen Verwendung Health-promoting agent and its use |
| 05/08/2008 | DE202006020223U1 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 05/08/2008 | DE102006051796A1 Triaza-benzo[e]azulenderivate Triaza-benzo [e] azulene derivatives |
| 05/08/2008 | DE102006051625A1 Kombinationstherapie substituierter Oxazolidinone Combination therapy substituted oxazolidinones |
| 05/08/2008 | DE102006049618A1 Triazine und Ihre Verwendung als Metalloproteinase-Inhibitoren Triazines and their use as metalloproteinase inhibitors |
| 05/08/2008 | DE102006049452A1 Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln Tetrahydropyrolopiperazin substituted compounds and their use in medicaments |
| 05/08/2008 | CA2822776A1 Inhibitors of histone deacetylase |
| 05/08/2008 | CA2704279A1 Method of treating demyelination diseases |
| 05/08/2008 | CA2704145A1 Butyrylcholinesterase inhibitors and their use in the treatment of neurodegenerative diseases |
| 05/08/2008 | CA2685724A1 New use 541 |
| 05/08/2008 | CA2671310A1 Bead based receptor biology |
| 05/08/2008 | CA2668562A1 Triazabenzo(e)azulene derivatives for the treatment of tumours |
| 05/08/2008 | CA2668551A1 Treatment of gastrointestinal diseases |
| 05/08/2008 | CA2668544A1 Process for production of 1-hydroxy-19-norcyclovitamin d derivative and intermediate for the production |
| 05/08/2008 | CA2668504A1 Diazepane-acetamide derivatives as selective 11.beta.-hsd1 inhibitors |
| 05/08/2008 | CA2668491A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |
| 05/08/2008 | CA2668454A1 Substituted 2-imidazoles |